Navigation Links
Thalidomide is the new approved drug for treating multiple cancers

Therapeutic Goods Administration (TGA) had approved the drug for use to treat the cancer multiple myeloma in 2003. This was revealed by a spokeswoman for the Department of Health and Ageing. It is available through Pharmaceutical Benefits Scheme.//

"The next step with any drug is to go to the PBS," as said by the spokesperson.

The history of the drug use reveals that the drug was originally used in Australia in the late 1950s and early 1960s to treat morning sickness and as a sedative but was taken off market around the world after it caused birth defects and miscarriages.

"The drug fell into disrepute because of miscarriages and its effect on the unborn child, however over the years it has been found to be very effective drug for other things," she said.

Even now the drug comes with a strict warning not to be used by pregnant women, women planning to become pregnant, or the male partners of women who are planning to become pregnant. "The TGA approved the drug under strict regulations," she said.


'"/>




Page: 1

Related medicine news :

1. Thalidomide may stage a comeback
2. Thalidomide for Tumor Treatment
3. Abortion Pill approved by FDA
4. Another injectable contraceptive Pill approved by FDA
5. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
6. New oral antiviral treatment of cold sores approved
7. Drug regulatory officials giving the nod for sale of Unapproved drug formulations in India
8. The Central Government of India had issued a list of approved ingredients for use in ayurvedic, siddha, unani drugs
9. Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki
10. IGF-1 drug approved by FDA
11. Health Canada Gave Access To Unapproved Drugs To AIDS/HIV Patients.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2016)... ... February 06, 2016 , ... FOR INFORMATION: ... AORN SURGICAL CONFERENCE & EXPO , WHAT:     , This conference is the ... perioperative nurses in attendance to study the latest evidence-based recommendations and resources ...
(Date:2/6/2016)... ... February 06, 2016 , ... Research has shown ... to reduce the frequency and level of relapse. , At the ... and Purpose,” will explore the critical tasks of the recovery phase and beyond ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Today, the Whole-Food ... announced that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian cuisine, ... Network. , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis highlights ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... announce the addition of micro-needling services in their Napa Valley office. The technique ... of Plastic Surgery Associates, Dr. Canales and Dr. Furnas, are part of only ...
(Date:2/5/2016)... ... February 05, 2016 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... again host, Swirl, A Wine Tasting Event at the La Gorce Country Club ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... SAN DIEGO , Feb. 5, 2016 Aethlon ... Jim Joyce , Chairman and CEO, will be presenting at ... New York, NY at 2:15 p.m. ... participate in an Immunotherapy Panel discussion taking place at 3:15 ... available for replay approximately one hour after the conclusion of ...
(Date:2/5/2016)... February 5, 2016 --> ... report states that the global active pharmaceuticals ingredients (APIs) ... predicted to reach US$185.9 bn by 2020. It is ... 2014 to 2020. The title of the report is ... by Geography, and by Therapeutic Area) - Global Industry ...
(Date:2/5/2016)... 5, 2016  Zimmer Biomet Holdings, Inc. (NYSE and ... announced underwritten secondary offering of 11,027,558 shares of its ... affiliates of Blackstone and Goldman Sachs.  The shares are ... of $96.45 per share. The selling stockholders will receive ... Biomet nor any of its directors, officers or other ...
Breaking Medicine Technology: